首页> 外文期刊>Journal of Molecular and Cellular Cardiology >Mitochondrial ROS generation following acetylcholine-induced EGF receptor transactivation requires metalloproteinase cleavage of proHB-EGF.
【24h】

Mitochondrial ROS generation following acetylcholine-induced EGF receptor transactivation requires metalloproteinase cleavage of proHB-EGF.

机译:乙酰胆碱诱导的EGF受体反式激活后,线粒体ROS的产生需要proHB-EGF的金属蛋白酶裂解。

获取原文
获取原文并翻译 | 示例
           

摘要

Acetylcholine (ACh) mimics ischemic preconditioning by a mechanism dependent on phosphatidylinositol 3-kinase (PI3-kinase) and reactive oxygen species (ROS). In other tissues muscarinic receptors activate a metalloproteinase, which liberates surface-associated heparin-binding epidermal growth factor (HB-EGF) and causes transactivation of epidermal growth factor receptors (EGFRs) with activation of PI3-kinase. We tested whether this pathway is operative in myocardium. Adult rabbit cardiomyocytes were incubated in reduced MitoTracker Red, which fluoresces after ROS exposure. ACh caused a 36 +/- 6% increase in fluorescence (P < 0.001) and metalloproteinase inhibitor III (MPI) abolished this increase. Both exogenous EGF as well as HB-EGF caused similar increases in the ROS signal (41 +/- 12%, P = 0.005 and 40 +/- 7%, P < 0.001, respectively). The ROS burst from HB-EGF was unaffected by MPI (37 +/- 6%, P = 0.002), confirming that inhibition of metalloproteinase activity blocked ACh's effect at a site upstream of EGFR. CRM-197, which inhibits HB-EGF activity, also blocked ACh-induced ROS generation, again implicating release of HB-EGF as a necessary step for ROS generation. An HB-EGF-neutralizing antibody also prevented ACh-induced increase in ROS. In isolated, perfused rabbit hearts ACh increased phosphorylation of EGFR by 127.4 +/- 43.7%, and this increase was abolished by MPI. Finally, ACh decreased infarct size from 30.1 +/- 2.9% of the risk zone in control hearts to 13.7 +/- 3.0% (P = 0.002), and this protection could be abolished by co-treatment with MPI (28.7 +/- 2.6%, P = n.s. vs. control). Stimulation of a second G(i)-protein-coupled receptor by the delta-opioid agonist [D-Ala(2), D-Leu(5)]-enkephalin acetate (DADLE) also protected the heart (9.1 +/- 2.0% infarction, P < 0.005 vs. control), and this protection was similarly blocked by MPI (28.9 +/- 2.3% infarction). We conclude that ACh-induced ROS generation in myocytes is mediated via transactivation of EGFR through metalloproteinase-dependent release of HB-EGF, and that this pathway is also operative in the intact heart and is required for ACh's cardioprotection.
机译:乙酰胆碱(ACh)通过依赖于磷脂酰肌醇3-激酶(PI3-激酶)和活性氧(ROS)的机制模拟缺血预处理。在其他组织中,毒蕈碱受体激活金属蛋白酶,该酶释放与表面相关的肝素结合表皮生长因子(HB-EGF),并通过激活PI3-激酶引起表皮生长因子受体(EGFR)的反式激活。我们测试了该途径在心肌中是否有效。将成年兔心肌细胞在减少的MitoTracker Red中孵育,后者在ROS暴露后发出荧光。 ACh导致荧光增加36 +/- 6%(P <0.001),金属蛋白酶抑制剂III(MPI)取消了这种增加。外源性EGF和HB-EGF都引起ROS信号的相似增加(分别为41 +/- 12%,P = 0.005和40 +/- 7%,P <0.001)。 MPI不会影响HB-EGF的ROS爆发(37 +/- 6%,P = 0.002),这证实了金属蛋白酶活性的抑制在EGFR上游位点阻断了ACh的作用。抑制HB-EGF活性的CRM-197也阻断了ACh诱导的ROS生成,再次暗示释放HB-EGF是ROS生成的必要步骤。 HB-EGF中和抗体也可以防止ACh诱导的ROS升高。在离体的灌注兔心脏中,ACh使EGFR的磷酸化增加了127.4 +/- 43.7%,MPI取消了这种增加。最后,ACh将梗死面积从对照心脏的危险区域的30.1 +/- 2.9%减少到13.7 +/- 3.0%(P = 0.002),并且可以通过与MPI共同治疗(28.7 +/-)取消这种保护。 2.6%,P = ns(相对于对照)。阿片类阿片激动剂[D-Ala(2),D-Leu(5)]-乙酸脑啡肽(DADLE)对第二个G(i)蛋白偶联受体的刺激也保护了心脏(9.1 +/- 2.0 %梗塞,相对于对照,P <0.005),并且该保护类似地被MPI(28.9 +/- 2.3%梗塞)阻断。我们得出的结论是,通过金属蛋白酶依赖性释放的HB-EGF,EGFR的反式激活介导了ACh诱导的心肌细胞中ROS的产生,并且该途径在完整的心脏中也有效,并且是ACh的心脏保护所必需的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号